Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin Short Flex vs Long Flex in Cervical Dystonia
NCT01486264Phase 4Completed
- Sponsor
- Merz
- Start
- Jan 2012
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of incobotulinumtoxinA in cervical dystonia (CD) (2 arms), sponsored by Merz. Primary endpoint: Toronto Western Spasmodic Torticollis Rating Scale Severity Subscale Score. Started Jan 2012; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT01486264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486264.